Comparative analysis of roxadustat efficacy between maintenance hemodialysis and peritoneal dialysis patients
CONCLUSION: Roxadustat can effectively increase the hemoglobin level of maintenance dialysis patients, even in those with low erythropoietin response or erythropoietin resistance, and, more importantly, its efficacy in PD patients was more significant.PMID:37877297 | DOI:10.5414/CN111144
Source: Clinical Nephrology - Category: Urology & Nephrology Authors: Liling Zhang Yan Huang Defeng Yin Tingting Zhu Qi Liu Ying Li Linwang Gan Source Type: research
More News: Anemia | Cholesterol | Dialysis | Hemodialysis | Iron | Peritoneal Dialysis | Study | Urology & Nephrology